Regulatory, financial and tech company expertise.
Goodwin’s clean technology and energy practice focuses on entrepreneurs, operating companies, and investors who are pioneers in the clean tech and energy markets. We’re currently counsel to over 2,500 technology-based clients, including some of the leading wind, solar and biofuels companies and represent 400 venture capital and private equity firms, leveraging relationships with investors on behalf of our clients. And with the breakneck pace of technology disrupting industries around the world, we have a team that is equally proficient in advising the innovators and the investors across the private equity, technology, healthcare and life sciences sectors.
The convergence of the technology and private equity industries allows Goodwin to offer a truly unique, blended service offering to companies and investors alike. A deep understanding of both industries is critical for deal execution and sourcing, and growth equity that blends venture capital and private equity. We guide clients through M&A transactions and provide a variety of financial services. We help clients develop and finance clean technology manufacturing facilities and renewable energy power generation projects. Litigators with extensive courtroom experience in the tech sector protect client interests and provide strategies for avoiding litigation when possible. Our collective expertise helps clients capitalize on opportunities while anticipating and minimizing the risks in such ventures.
As part of our client commitment, we’re well attuned to new and evolving government policies that foster growth in the industry. With more than 20 former government officials in our practice, we understand the intricacies of government agencies and the decision-making process, and advocate for fair and reasonable outcomes that will support the future of clean technology.
Companies involved in cross-border transactions face numerous regulatory hurdles relating to the export and re-export of sensitive goods and technologies; investments and other dealings having national security implications; and relationships with persons and entities that may be governed by U.S. economic sanctions, anti-money laundering and anti-corruption laws.
As a growing technology company, your prospects are exciting and your challenges are unique – from securing funding, protecting IP, and navigating the regulatory environment, to differentiating yourself in the marketplace, managing customer acquisition and scaling your business. We get it. Our dedicated team brings a comprehensive, coordinated approach that interconnects business, new technologies and the law. Our depth of experience in the private equity space along with our technology, healthcare and life sciences lawyers makes Goodwin uniquely suited to harness the breakneck pace of technology. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.
Companies involved in cross-border transactions face numerous regulatory hurdles relating to the export and re-export of sensitive goods and technologies; investments and other dealings having national security implications; and relationships with persons and entities that may be governed by U.S. economic sanctions, anti-money laundering and anti-corruption laws.
As a growing technology company, your prospects are exciting and your challenges are unique – from securing funding, protecting IP, and navigating the regulatory environment, to differentiating yourself in the marketplace, managing customer acquisition and scaling your business. We get it. Our dedicated team brings a comprehensive, coordinated approach that interconnects business, new technologies and the law. Our depth of experience in the private equity space along with our technology, healthcare and life sciences lawyers makes Goodwin uniquely suited to harness the breakneck pace of technology. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.